dc.contributor.author |
Constantinou-Kokotou, V |
en |
dc.contributor.author |
Magrioti, V |
en |
dc.contributor.author |
Verger, R |
en |
dc.date.accessioned |
2014-06-06T06:46:08Z |
|
dc.date.available |
2014-06-06T06:46:08Z |
|
dc.date.issued |
2004 |
en |
dc.identifier.issn |
09476539 |
en |
dc.identifier.uri |
http://dx.doi.org/10.1002/chem.200305573 |
en |
dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/2802 |
|
dc.subject |
Enzyme inhibitors |
en |
dc.subject |
Enzymes |
en |
dc.subject |
Lipids |
en |
dc.subject |
Monolayers |
en |
dc.subject |
Triacylglycerol analogues |
en |
dc.subject.other |
Fatty acids |
en |
dc.subject.other |
Glycerol |
en |
dc.subject.other |
Interfaces (materials) |
en |
dc.subject.other |
Isotherms |
en |
dc.subject.other |
Monolayers |
en |
dc.subject.other |
Surface phenomena |
en |
dc.subject.other |
Synthesis (chemical) |
en |
dc.subject.other |
Human digestive lipases |
en |
dc.subject.other |
Surface pressure |
en |
dc.subject.other |
Enzyme inhibition |
en |
dc.subject.other |
enzyme inhibitor |
en |
dc.subject.other |
fatty acid derivative |
en |
dc.subject.other |
glycerol derivative |
en |
dc.subject.other |
glycerol didecanoate |
en |
dc.subject.other |
methyl group |
en |
dc.subject.other |
oleic acid |
en |
dc.subject.other |
triacylglycerol |
en |
dc.subject.other |
triacylglycerol derivative |
en |
dc.subject.other |
triacylglycerol lipase |
en |
dc.subject.other |
triacylglycerol lipase inhibitor |
en |
dc.subject.other |
triolein |
en |
dc.subject.other |
unclassified drug |
en |
dc.subject.other |
article |
en |
dc.subject.other |
compression |
en |
dc.subject.other |
concentration response |
en |
dc.subject.other |
controlled study |
en |
dc.subject.other |
drug design |
en |
dc.subject.other |
drug potency |
en |
dc.subject.other |
drug structure |
en |
dc.subject.other |
drug synthesis |
en |
dc.subject.other |
enzyme activity |
en |
dc.subject.other |
enzyme assay |
en |
dc.subject.other |
enzyme inhibition |
en |
dc.subject.other |
film |
en |
dc.subject.other |
human |
en |
dc.subject.other |
molecular stability |
en |
dc.subject.other |
parameter |
en |
dc.subject.other |
stereospecificity |
en |
dc.subject.other |
surface property |
en |
dc.subject.other |
technique |
en |
dc.subject.other |
Enzyme Inhibitors |
en |
dc.subject.other |
Humans |
en |
dc.subject.other |
Lipase |
en |
dc.subject.other |
Membranes, Artificial |
en |
dc.subject.other |
Surface Properties |
en |
dc.subject.other |
Triglycerides |
en |
dc.title |
Sterically Hindered Triacylglycerol Analogues as Potent Inhibitors of Human Digestive Lipases |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1002/chem.200305573 |
en |
heal.publicationDate |
2004 |
en |
heal.abstract |
A novel class of inhibitors of human digestive lipases have been developed. Various sterically hindered triacylglycerols based on 2-methyl- and 2-butylglycerol, and/or 2-methyl fatty acids were synthesized. The triacylglycerol analogues were tested for their ability to form stable monomolecular films at the air/water interface by recording their surface-pressure/molecular-area compression isotherms. The inhibition of human pancreatic and gastric lipases by the sterically hindered triacylglycerol analogues was studied by using the monolayer technique with mixed films of 1,2-dicaprin, which contained variable proportions of each inhibitor. Triolein analogues that contain a butyl group at the 2-position of the glycerol backbone or methyl groups both at the 2-position of glycerol, and the α-position of each oleic acid residue were potent inhibitors; this caused a 50% decrease in HPL activity at 0.003 molar fraction. |
en |
heal.journalName |
Chemistry - A European Journal |
en |
dc.identifier.issue |
5 |
en |
dc.identifier.volume |
10 |
en |
dc.identifier.doi |
10.1002/chem.200305573 |
en |
dc.identifier.spage |
1133 |
en |
dc.identifier.epage |
1140 |
en |